Online Health Survey of Patients With Vitiligo Vulgaris/ Online Survey of Pediatric Patients With Vitiligo
NCT ID: NCT01401374
Last Updated: 2017-04-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
3258 participants
OBSERVATIONAL
2011-03-31
2016-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Questionnaire and Laboratory Data on Vitiligo Vulgaris
NCT01206374
The Gut and Skin Microbiome in Vitiligo Disease Progression
NCT03577327
Photoprotection Habits in Patients With Vitiligo
NCT03323125
Stress Response Pathways in Vitiligo
NCT02797574
Translational Assessment of Vitiligo According to Body Locations
NCT06068218
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vitiligo Patients
patients with vitiligo vulgaris
No interventions assigned to this group
Controls
Individuals without vitiligo vulgaris
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
St. Luke's-Roosevelt Hospital Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nanette Silverberg, MD
Role: PRINCIPAL_INVESTIGATOR
St. Luke's-Roosevelt Hospital Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St. Luke's-Roosevelt Hospital Center
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Silverberg JI, Reja M, Silverberg NB. Regional variation of and association of US birthplace with vitiligo extent. JAMA Dermatol. 2014 Dec;150(12):1298-305. doi: 10.1001/jamadermatol.2014.899.
Silverberg JI, Silverberg NB. Quality of life impairment in children and adolescents with vitiligo. Pediatr Dermatol. 2014 May-Jun;31(3):309-18. doi: 10.1111/pde.12226. Epub 2013 Oct 18.
Silverberg JI, Silverberg NB. Association between vitiligo extent and distribution and quality-of-life impairment. JAMA Dermatol. 2013 Feb;149(2):159-64. doi: 10.1001/jamadermatol.2013.927.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
10-148/10-149x
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.